Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Oxford Clinical Trials Research Unit

We would like to make everyone aware that the OCTRU office continues to be contactable during the current situation regarding COVID-19.

If you have any queries please continue to contact us at octrutrialshub@ndorms.ox.ac.uk or for queries about specific trials, please contact the trial teams directly on the numbers on your information sheets or the trial websites.   

OCTRU

ABOUT US      THEMES      TRIALS PORTFOLIO      NEWS      TRAINING      INTERVENTIONS      OUR TEAM      METHODOLOGY RESEARCH      CTU INFOGRAPHICS

Welcome

Welcome to the OCTRU website. The University of Oxford has a long standing tradition in clinical trials and OCTRU based within the University is one of the UKCRC's registered clinical trials units.

Latest News

Dupuytren’s disease hand examination.

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Tim Theologis

Three NIHR HTA grants awarded to Professor Tim Theologis

Congratulations to Professor Tim Theologis, who has been awarded three NIHR HTA grants to extend research in orthopaedic disorders in children.

AFTER study opens to recruitment

Going straight to surgery found to be better than undergoing rehabilitation first for longstanding anterior cruciate ligament injury

New research, funded by the National Institute for Health and Care Research (NIHR), shows initial surgery to be more successful and cost effective than undergoing treatment with rehabilitation first to treat longstanding anterior cruciate ligament injury.

NIHR CTU SUPPORT

PLEASE NOTE: This unit receives National Institute for Health Research CTU Support Funding. This funding has been awarded to support the unit in developing and supporting NIHR trials.

Would you like to collaborate with OCTRU?

OCTRU welcomes requests to collaborate, look to see which of our themes your collaboration may fit within. 

Find out more